# Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients

> **NCT03007225** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 50 (actual)

## Conditions studied

- HepatoCellular Carcinoma

## Interventions

- **DRUG:** Trans-arterial chemoembolization (TACE)
- **DRUG:** TACE with Drug Eluting Beads procedure

## Key facts

- **NCT ID:** NCT03007225
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007225, "Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03007225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*